Sotorasib
Targeted TherapyApproved for: NSCLCBiomarker: KRAS G12C Sotorasib is the first treatment for adult patients with non–small cell lung cancer whose tumors harbor KRAS G12C mutations and who have received at least 1 prior systemic therapy. Related Research News Pre-...